| A molecularly annotated platform of patient-derived xenografts (“xenopatients”) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer A Bertotti, G Migliardi, F Galimi, F Sassi, D Torti, C Isella, D Corà, ... Cancer discovery 1 (6), 508-523, 2011 | 1047 | 2011 |
| The 2019 WHO classification of tumours of the breast PH Tan, I Ellis, K Allison, E Brogi, SB Fox, S Lakhani, AJ Lazar, EA Morris, ... Histopathology 77 (2), 2020 | 720 | 2020 |
| Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance E Devarajan, AA Sahin, JS Chen, RR Krishnamurthy, N Aggarwal, ... Oncogene 21 (57), 8843-8851, 2002 | 585 | 2002 |
| Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast … P Cassoni, M Papotti, C Ghè, F Catapano, A Sapino, A Graziani, ... The Journal of Clinical Endocrinology & Metabolism 86 (4), 1738-1745, 2001 | 501 | 2001 |
| Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer G Cserni, D Gregori, F Merletti, A Sapino, MP Mano, A Ponti, S Sandrucci, ... Journal of British Surgery 91 (10), 1245-1252, 2004 | 371 | 2004 |
| Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond C Marchiò, L Annaratone, A Marques, L Casorzo, E Berrino, A Sapino Seminars in cancer biology 72, 123-135, 2021 | 282 | 2021 |
| Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines G Cserni, I Amendoeira, N Apostolikas, JP Bellocq, S Bianchi, G Bussolati, ... European Journal of Cancer 39 (12), 1654-1667, 2003 | 278 | 2003 |
| Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up S Bustreo, S Osella-Abate, P Cassoni, M Donadio, M Airoldi, F Pedani, ... Breast cancer research and treatment 157, 363-371, 2016 | 276 | 2016 |
| SF3B1 mutations constitute a novel therapeutic target in breast cancer SL Maguire, A Leonidou, P Wai, C Marchiò, CKY Ng, A Sapino, ... The Journal of pathology 235 (4), 571-580, 2015 | 260 | 2015 |
| Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers I Castellano, E Allia, V Accortanzo, AM Vandone, L Chiusa, R Arisio, ... Breast cancer research and treatment 124, 607-617, 2010 | 250 | 2010 |
| Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray‐based CGH analysis C Marchio, MB Lambros, P Gugliotta, LV Di Cantogno, C Botta, B Pasini, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009 | 232 | 2009 |
| Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for … G Cserni, I Amendoeira, N Apostolikas, JP Bellocq, S Bianchi, W Boecker, ... Journal of Clinical Pathology 57 (7), 695-701, 2004 | 228 | 2004 |
| Expression of the neuroendocrine phenotype in carcinomas of the breast. A Sapino, L Righi, P Cassoni, M Papotti, F Pietribiasi, G Bussolati Seminars in diagnostic pathology 17 (2), 127-137, 2000 | 204 | 2000 |
| The requirements of a specialist breast centre L Biganzoli, F Cardoso, M Beishon, D Cameron, L Cataliotti, CE Coles, ... The Breast 51, 65-84, 2020 | 200 | 2020 |
| HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary … S Doublier, DC Belisario, M Polimeni, L Annaratone, C Riganti, E Allia, ... BMC cancer 12, 1-15, 2012 | 197 | 2012 |
| Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management A Sapino, P Cassoni, E Zanon, F Fraire, S Croce, C Coluccia, M Donadio, ... British journal of cancer 88 (5), 702-706, 2003 | 195 | 2003 |
| Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast C Marchio, M Iravani, R Natrajan, MB Lambros, K Savage, N Tamber, ... The Journal of pathology 215 (4), 398-410, 2008 | 177 | 2008 |
| Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women A Sapino, L Righi, P Cassoni, M Papotti, P Gugliotta, G Bussolati Modern Pathology 14 (8), 768-776, 2001 | 175 | 2001 |
| p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene–dependent breast tumorigenesis S Cabodi, A Tinnirello, P Di Stefano, B Bisarò, E Ambrosino, I Castellano, ... Cancer research 66 (9), 4672-4680, 2006 | 174 | 2006 |
| Specific demonstration of myoepithelial cells by anti-alpha smooth muscle actin antibody. P Gugliotta, A Sapino, L Macrí, O Skalli, G Gabbiani, G Bussolati Journal of Histochemistry & Cytochemistry 36 (6), 659-663, 1988 | 167 | 1988 |
